Home Featured Page 219

Featured

Latest

The Psychedelic News Feed: December 8 – 14, 2025

The Psychedelic Practitioner Issue 2: Preparation

Evidence and Experience: Samuel Wilkinson on the State of (Es)ketamine Therapy and What Comes Next

The Psychedelic News Feed: December 1 – 7, 2025

The Psychedelic News Feed: November 24 – 30, 2025

Psychedelic Bulletin: Delix Raises $70m Series A; Toronto Gets Psychedelics Research...

PTSF79 – Psychedelic Facilitator Abuse and Space Holding Ethics with Dr....

MindMed Announces Appointment of Andreas Krebs and Carol Vallone as Directors...

MINDCURE Announces Commencement of Trading on the OTCQX Best Market

Psyence Group and Pure Extracts Finalize “Pure Psyence,” A Joint Venture...

PharmaTher Announces Closing of CAD$10 Million Private Placement with Institutional Investors

PharmaTher Retains Former FDA Psychiatry Division Director Dr. Thomas Laughren as...

Mindset Pharma Expands Pipeline: Identifies Additional Next Generation 5-MeO-DMT-Inspired Lead Candidates

Red Light Holland: Initial Results From Red Light Oregon Market Research...

Psychedelics and Pregnancy: A Look Into the Safety, Research and Legality

1...218219220...304 Page 219 of 304

The Psychedelic News Feed: December 8 – 14, 2025

The Psychedelic Practitioner Issue 2: Preparation

Evidence and Experience: Samuel Wilkinson on the State of (Es)ketamine Therapy...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

The Psychedelic News Feed: December 8 – 14, 2025

The Psychedelic Practitioner Issue 2: Preparation

Evidence and Experience: Samuel Wilkinson on the State of (Es)ketamine Therapy and What Comes Next

The Psychedelic News Feed: December 1 – 7, 2025

The Psychedelic News Feed: November 24 – 30, 2025

Psychedelic Bulletin: Delix Raises $70m Series A; Toronto Gets Psychedelics Research...

PTSF79 – Psychedelic Facilitator Abuse and Space Holding Ethics with Dr....

MindMed Announces Appointment of Andreas Krebs and Carol Vallone as Directors...

MINDCURE Announces Commencement of Trading on the OTCQX Best Market

Psyence Group and Pure Extracts Finalize “Pure Psyence,” A Joint Venture...

PharmaTher Announces Closing of CAD$10 Million Private Placement with Institutional Investors

PharmaTher Retains Former FDA Psychiatry Division Director Dr. Thomas Laughren as...

Mindset Pharma Expands Pipeline: Identifies Additional Next Generation 5-MeO-DMT-Inspired Lead Candidates

Red Light Holland: Initial Results From Red Light Oregon Market Research...

Psychedelics and Pregnancy: A Look Into the Safety, Research and Legality

EDITOR PICKS

The Psychedelic News Feed: December 8 – 14, 2025

The Psychedelic Practitioner Issue 2: Preparation

Evidence and Experience: Samuel Wilkinson on the State of (Es)ketamine Therapy...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY